Evidence map›Paper›PMID 36846314›Full record

ReviewMRS bulletin2023

Latest advances on MXenes in biomedical research and health care.

Raghav Garg, Flavia Vitale

Abstract readReview
In one paragraph

Review in MRS bulletin, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Size Scaling of the Electrochemical Performance of TiSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Size Scaling of the Electrochemical Performance of TibioRxiv : the preprint server for biology · 2026
    Article
  8. Review
  9. Review
  10. Astrocyte Interactions With TiAdvanced materials interfaces · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Recent Trends in Biomedical Applications of CuInternational journal of nanomedicine · 2025
    Review
  16. Atomically thin bioelectronics.Nature reviews. Materials · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Raghav GargDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.ORCID 0000-0002-3501-6892
Flavia VitaleDepartment of Neurology, University of Pennsylvania, Philadelphia, USA.ORCID 0000-0001-8644-550X

Funding

Interdisciplinary Engineering Career Development Center in Movement and Rehabilitation SciencesK12HD073945 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI DEWALD, JULIUS P, REINKENSMEYER, DAVID JAY · 2012 to 2021
$7.9M
Validating MXene Electrodes for Next-Generation ElectroencephalographyR01NS121219 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MEDAGLIA, JOHN, VITALE, FLAVIA · 2021 to 2025
$2.3M
Defining neuromechanical mechanisms of Achilles tendinopathyR01AR081062 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BAXTER, JOSH, VITALE, FLAVIA · 2022 to 2025
$1.3M
NIAMS NIH HHS R01 AR081062NICHD NIH HHS K12 HD073945NINDS NIH HHS R01 NS121219
6 · The paper itself

Abstract

The unique combination of physical and chemical properties of MXenes has propelled a growing number of applications in biomedicine and healthcare. The expanding library of MXenes with tunable properties is paving the way for high-performance, application-specific MXene-based sensing and therapeutic platforms. In this article, we highlight the emerging biomedical applications of MXenes with specific emphasis on bioelectronics, biosensors, tissue engineering, and therapeutics. We present examples of MXenes and their composites enabling novel technological platforms and therapeutic strategies, and elucidate potential avenues for further developments. Finally, we discuss the materials, manufacturing, and regulatory challenges that need to be synergistically addressed for the clinical translation of MXene-based biomedical technologies. Graphical abstract:

Indexed as

BioelectronicsBiosensingClinical translationMXeneTherapeuticsTissue engineering

Identifiers

PMID36846314
PMCPMC9943034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.